finasteride has been researched along with Syndrome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Irwig, MS | 1 |
| Romero Pérez, P | 1 |
| Gray, SL; Semla, TP | 1 |
| Traish, AM | 1 |
| Niederberger, C | 1 |
| Kaczmarek, IA; Prost, ME; Wasyluk, J | 1 |
| Borda, LJ; Mervis, JS; Miteva, M | 1 |
| Diviccaro, S; Giatti, S; Melcangi, RC; Panzica, G | 1 |
| Ganzer, CA; Jacobs, AR | 1 |
| Daneshmand, S; Shamie, N; Zhang, Y | 1 |
| Luzzi, GA | 1 |
| Te, AE; Yang, J | 1 |
| Potts, JM | 1 |
| Dagres, E; Issa, SA | 1 |
| Leskinen, M; Lukkarinen, O; Marttila, T | 1 |
7 review(s) available for finasteride and Syndrome
| Article | Year |
|---|---|
Post-Finasteride Syndrome. Literature Review.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Humans; Iatrogenic Disease; Male; Prostatic Hyperplasia; Retrospective Studies; Syndrome | 2022 |
Post-finasteride syndrome: a surmountable challenge for clinicians.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Clinical Trials as Topic; Finasteride; Humans; Male; Observational Studies as Topic; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment | 2020 |
Topics: 5-alpha Reductase Inhibitors; Finasteride; Humans; Syndrome | 2021 |
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
Topics: Alopecia; Antidepressive Agents; Depression; Female; Finasteride; Humans; Iatrogenic Disease; Libido; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Syndrome | 2018 |
Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.
Topics: Adrenergic alpha-Antagonists; Anti-Bacterial Agents; Chronic Disease; Diagnosis, Differential; Enzyme Inhibitors; Finasteride; Humans; Male; Pelvic Pain; Prostatitis; Quercetin; Syndrome | 2002 |
Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Enzyme Inhibitors; Finasteride; Humans; Male; Pelvic Pain; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Prostatitis; Serenoa; Syndrome; Treatment Outcome | 2005 |
Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents; Enzyme Inhibitors; Finasteride; Humans; Male; Pelvic Pain; Phytotherapy; Plant Extracts; Prostatitis; Secale; Syndrome | 2005 |
1 trial(s) available for finasteride and Syndrome
| Article | Year |
|---|---|
Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study.
Topics: Adult; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Inflammation; Male; Middle Aged; Pelvic Pain; Pilot Projects; Syndrome | 1999 |
8 other study(ies) available for finasteride and Syndrome
| Article | Year |
|---|---|
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effects.
Topics: Finasteride; Genital Diseases, Male; Humans; Male; Pharmacovigilance; Sexual Dysfunction, Physiological; Syndrome; Urological Agents | 2022 |
Post-finasteride syndrome.
Topics: 5-alpha Reductase Inhibitors; Finasteride; Humans; Male; Mental Disorders; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment | 2019 |
Re: Post-Finasteride Syndrome: A Surmountable Challenge for Clinicians.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Humans; Syndrome | 2020 |
Clinical risk factors associated with intraoperative floppy iris syndrome: a prospective study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Female; Finasteride; Follow-Up Studies; Humans; Incidence; Intraoperative Complications; Iris; Iris Diseases; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Poland; Prospective Studies; Risk Assessment; Risk Factors; Syndrome; Tamsulosin | 2019 |
'Post-finasteride syndrome': what to tell our female patients?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dose-Response Relationship, Drug; Female; Finasteride; Headache; Humans; Libido; Prevalence; Product Surveillance, Postmarketing; Sexual Dysfunctions, Psychological; Syndrome | 2018 |
Emotional Consequences of Finasteride: Fool's Gold.
Topics: Adult; Age Factors; Alopecia; Anxiety; Cross-Sectional Studies; Depression; Drug-Related Side Effects and Adverse Reactions; Emotions; Female; Finasteride; Humans; Incidence; Male; Patient Reported Outcome Measures; Pharmacovigilance; Risk Assessment; Sex Factors; Surveys and Questionnaires; Syndrome; United States; Young Adult | 2018 |
Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Competence; Fellowships and Scholarships; Female; Finasteride; Health Knowledge, Attitudes, Practice; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Medical Staff, Hospital; Ophthalmology; Patient Education as Topic; Prazosin; Prostatic Hyperplasia; Referral and Consultation; Sulfonamides; Surveys and Questionnaires; Syndrome; Tamsulosin; Urological Agents; Urology; Vision Disorders | 2016 |
Intraoperative floppy-iris syndrome and finasteride intake.
Topics: Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Humans; Intraoperative Complications; Iris Diseases; Male; Phacoemulsification; Prostatic Hyperplasia; Pupil; Syndrome | 2007 |